Monday, December 19, 2016

Genetic biomarker IDs patients with increased risk for heart damage by anthracycline chemo

Among women with breast cancer who received a type of chemotherapy called an anthracycline, those who had a certain genetic biomarker had a significantly increased risk for having anthracycline-induced congestive heart failure.



from Top Health News – ScienceDaily http://ift.tt/2h2vTrB
from Tumblr http://ift.tt/2hMfIxn

No comments:

Post a Comment